News
-
Conference on Personalised Medicine showcases impactful Research and its Implementation in Europe
The European Partnership for Personalised Medicine (EP PerMed) organised a conference on personalised medicine research on 11 and 12 February 2025 in Berlin, Germany. The conference brought together around 250 international experts in the areas of personalised medicine to present and discuss cutting-edge research and their successful translation into clinical practice.
-
EP PerMed Venture Creator Call: Webinar Recordings online
The EP PerMed Venture Creator Call offers researchers guidance from experienced mentors to effectively bring their pioneering work in personalised medicine to the market. The recording of the webinar for interested applicants on 28 January 2025 is now available.
-
EP PerMed hosts session at Europe Biobank Week 2025
EP PerMed is pleased to host Session 4 ‘Unlocking Biobanks for Personalised Medicine’ at the Europe Biobank Week on 15 May 2025 from 14:00 to 15:30.
EP PerMed JTC 2025
#PGxPM2025
With its second Joint Transnational Call (JTC), EP PerMed aims to fund human health research on pharmacogenomic strategies for personalised medicine approaches. The deadline for submission of pre-proposals is 18 February 2025. Funding decisions are expected to be communicated in October 2025.
EP PerMed Conference2025
EP PerMed will organise its first EP PerMed Conference on Personalised Medicine Research on 11 and 12 February 2025 in Berlin (Germany), followed by a Training Workshop on Scientific Integrity on 12 and 13 February.
Mission & Objectives
The vision of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
Dr. Wolfgang Ballensiefen, Coordinator
Governance & Boards
The European Partnership for Personalised Medicine gathers together more than 50 partners from over 20 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.